EUVIMEDEUVIMED entdecken
Crossref

The prognostic factors and treatment patterns of the first recurrence of retroperitoneal liposarcoma

Yoshiyuki Matsui, Shintaro Iwata, Konosuke Moritani, Aiko Maejima, Satoshi Nara, Yukinori Yamagata, Motokiyo Komiyama, Satoshi Kamio, Kan Yonemori, Akira Kawai, Hiroyuki Fujimoto

International Journal of Clinical Oncology · 2025

DOI: 10.1007/s10147-025-02790-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Clinical Oncology, 2025. Verfasst von Yoshiyuki Matsui und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. yomatsui@ncc.go.jp. Hauptthemen laut MEDLINE: Liposarcoma, Retroperitoneal Neoplasms, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: This study aimed to identify prognostic factors and treatment patterns at the first recurrence of retroperitoneal liposarcoma (LPS). METHODS: Medical records of 150 patients who underwent resection for primary retroperitoneal LPS were reviewed. Of the 94 patients with local or distant recurrence, prognostic factors and treatment approaches were retrospectively analyzed. RESULTS: At recurrence, 41 patients underwent surgery, 12 received radiation, 23 received chemotherapy, 12 were under active surveillance, and 6 received best supportive care. In univariate analysis, well-differentiated primary tumors predicted better overall survival (OS) compared to dedifferentiated tumors (p = 0.004). Conversely, shorter recurrence-free survival (RFS) after initial surgery, smaller recurrent tumors at treatment, and high neutrophil-to-lymphocyte ratio (NLR) at recurrence were associated with poorer OS (p = 0.0418, 0.007, and 0.0475, respectively). Treatment decisions were influenced by RFS, time from recurrence to treatment, initial tumor differentiation, recurrence site, and multiplicity. Among those who had surgery for recurrence, 29.2% (12/41) showed a change in tumor differentiation. RFS was a significant predictor of this change (p = 0.026). Additionally, NLR at recurrence and the waiting period from recurrence to treatment were significant prognostic factors in surgically treated patients (p = 0.005 and 0.028, respectively). CONCLUSIONS: RFS, timing of treatment, initial tumor differentiation, and recurrence characteristics influence treatment choices at first recurrence. RFS may predict changes in tumor differentiation, while NLR at recurrence and the waiting period from recurrence to treatment are important prognostic indicators in patients undergoing surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiposarcomaRetroperitoneal NeoplasmsNeoplasm Recurrence, LocalHumansMaleFemaleMiddle AgedPrognosisAgedRetrospective StudiesAdultAged, 80 and overDisease-Free SurvivalNeutrophils

Stichwörter der Autor:innen

Active surveillanceChemotherapyFirst recurrenceRadiationRetroperitoneal liposarcomaSurgery

Autor:innen und Institutionen

  • Department of Urology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. yomatsui@ncc.go.jp.
  • Department of Musculoskeletal Oncology and Rehabilitation Medicine, National Cancer Center Hospital, Tokyo, Japan. yomatsui@ncc.go.jp.
  • Department of Colorectal Surgery, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan. yomatsui@ncc.go.jp.
  • Department of Hepatobiliary and Pancreatic Surgery, National Cancer Center Hospital, Tokyo, Japan. yomatsui@ncc.go.jp.
  • Department of Gastric Surgery, National Cancer Center Hospital, Tokyo, Japan. yomatsui@ncc.go.jp.
  • Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan. yomatsui@ncc.go.jp.

Zitieren

APA

Matsui, Y., Iwata, S., Moritani, K., Maejima, A., Nara, S., Yamagata, Y., Komiyama, M., Kamio, S., Yonemori, K., Kawai, A., & Fujimoto, H. (2025). The prognostic factors and treatment patterns of the first recurrence of retroperitoneal liposarcoma. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-025-02790-6

Vancouver

Matsui Y, Iwata S, Moritani K, Maejima A, Nara S, Yamagata Y, et al. The prognostic factors and treatment patterns of the first recurrence of retroperitoneal liposarcoma. International Journal of Clinical Oncology. 2025. doi:10.1007/s10147-025-02790-6

BibTeX
@article{Matsui2025,
  author = {Matsui, Yoshiyuki and Iwata, Shintaro and Moritani, Konosuke and Maejima, Aiko and Nara, Satoshi and Yamagata, Yukinori and Komiyama, Motokiyo and Kamio, Satoshi and Yonemori, Kan and Kawai, Akira and Fujimoto, Hiroyuki},
  title = {The prognostic factors and treatment patterns of the first recurrence of retroperitoneal liposarcoma},
  journal = {International Journal of Clinical Oncology},
  year = {2025},
  doi = {10.1007/s10147-025-02790-6}
}
Kostenlos starten →